CLINICAL RESEARCH
Assessment of the relationship between serum vitamin (A, B12, C, D, folate) and zinc levels and polycystic ovary syndrome
More details
Hide details
Submission date: 2017-02-06
Acceptance date: 2017-03-14
Publication date: 2017-03-27
Arch Med Sci Civil Dis 2017;2(1):62-69
KEYWORDS
TOPICS
ABSTRACT
Introduction There is increasing evidence that vitamin D affects insulin and glucose metabolism, and a low vitamin D status is suspected to be a risk factor for impaired glucose tolerance, insulin resistance and so polycystic ovary syndrome (PCOS), but there is no evidence to suggest that there is a relationship between vitamin A, vitamin B12, vitamin C, folate, zinc (Zn) and PCOS in the literature. We aimed to investigate the levels of vitamins A, B12, C and D and zinc and the association between vitamins A, B12, C and D, folate and zinc level and hormonal-biochemical parameters in PCOS.
Material and methods: We recruited 65 women with PCOS and 67 healthy individuals. Correlations between clinical and metabolic parameters and vitamins A, B12, C and D and zinc status were analyzed separately in patients and controls.
Results: Women with PCOS showed a decreased serum level of vitamin A compared with the control group (p < 0.05), but they showed no differences in the levels of vitamin D, vitamin B12, vitamin C, folate or Zn (p > 0.05).
Conclusions: Our study found no differences in the absolute levels of serum vitamins B12, C, D, folate or Zn between PCOS patients and matched controls, but the vitamin A level was lower in PCOS patients. Prevalence of vitamins A, B12, C and D and Zn insufficiency was equally common among both patients and controls.
REFERENCES (19)
1.
Lord J, Wilkin T. Metformin in polycystic ovary syndrome. Curr Opin Obstet Gynecol 2004; 16: 481-6.
2.
Cebeci F, Onsun N, Mert M. Insulin resistance in women with hirsutism. Arch Med Sci 2012; 8: 342-6.
3.
Dunaif A, Segal KR, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38: 1165-74.
4.
Liu E, Meigs JB, Pittas AG, et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139: 329-34.
5.
Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-7.
6.
Balen AH, Laven JS, Tan SL, Dewailly D. Ultrasound assessment of the poly-cystic ovary: international consensus definitions. Hum Reprod Update 2003; 9: 505-14.
7.
Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004; 59: 141-54.
8.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
9.
Wood JR, Ho CKM, Nelson-Degrave VL, McAllister JM, Strauss JF. The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. J Reprod Immunol 2004; 63: 51-60.
10.
Wood JR, Nelson VL, Ho C, et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem 2003; 278: 26380-90.
11.
Wickenheisser JK, Nelson-DeGrave VL, Hendricks KL, et al. Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005; 90: 4858-65.
12.
Kilicdag EB, Bagis T, Tarim E, et al. Administration of B-group vitamins reduces circulating homocysteine in polycystic ovarian syndrome patients treated with metformin: a randomized trial. Hum Reprod 2005; 20: 1521-8.
13.
Kaya C, Cengiz SD, Satiroğlu H. Obesity and insulin resistance associated with lower plasma vitamin B12 in PCOS. Reprod Biomed Online 2009; 19: 721-6.
14.
Kurdoglu Z, Ozkol H, Tuluce Y, Koyuncu I. Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome. J Endocrinol Invest 2012; 35: 317-21.
15.
Zhang D, Luo WY, Liao H, Wang CF, Sun Y. The effects of oxidative stress to PCOS. Sichuan Da Xue Xue Bao Yi Xue Ban 2008; 39: 421-3.
16.
Li HWR, Brereton RE, Anderson RA, Wallace AM, Ho CKM. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metab Clin Exp 2011; 60: 1475-81.
17.
Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism 2011; 60: 1475-81.
18.
Mazloomi S, Sharifi F, Hajihosseini R, Kalantari S, Mazloomzadeh S. Association between hypoadiponectinemia and low serum concentrations of calcium and vitamin D in women with polycystic ovary syndrome. ISRN Endocrinol 2012; 2012: 949427.
19.
Ebisch IM, Thomas CM, Peters WH, Braat DD, Steegers-Theunissen RP. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility. Hum Reprod Update 2007; 13: 163-74.